SMTL ID : 7erd.1

Crystal structure of human Biliverdin IX-beta reductase B with Flunixin Meglumin (FMG)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 26 residues within 4Å: Chain A: G.10, T.12, G.13, Q.14, T.15, R.35, S.38, D.54, V.55, L.74, L.75, G.76, T.77, R.78, V.86, M.87, C.109, T.110, S.111, V.128, H.132, P.151, P.152, H.153, I.154 Ligands: JBO.2 33 PLIP interactions: 33 interactions with chain A Hydrophobic interactions: A:I.154 Hydrogen bonds: A:G.10, A:T.12, A:T.12, A:T.12, A:Q.14, A:Q.14, A:T.15, A:S.38, A:D.54, A:V.55, A:L.75, A:G.76, A:R.78, A:R.78, A:I.154, A:I.154 Water bridges: A:G.10, A:A.11, A:G.13, A:G.16, A:R.35, A:R.35, A:R.35, A:R.35, A:T.77, A:T.77, A:R.78, A:R.78 Salt bridges: A:R.35, A:R.78, A:R.78 pi-Cation interactions: A:R.35 NAP.4: 25 residues within 4Å: Chain B: G.10, A.11, T.12, G.13, Q.14, T.15, R.35, R.39, D.54, V.55, L.74, L.75, G.76, R.78, V.86, M.87, C.109, T.110, S.111, H.132, P.151, P.152, H.153, I.154 Ligands: JBO.5 26 PLIP interactions: 26 interactions with chain B Hydrophobic interactions: B:P.151, B:I.154 Hydrogen bonds: B:G.10, B:T.12, B:T.12, B:G.13, B:Q.14, B:Q.14, B:T.15, B:T.15, B:R.35, B:D.54, B:V.55, B:L.75, B:G.76, B:R.78, B:I.154 Water bridges: B:G.10, B:G.16, B:R.39, B:T.77 Salt bridges: B:R.35, B:R.39, B:R.78 pi-Cation interactions: B:R.35, B:R.35

2 x JBO: 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid(Non-covalent)

JBO.2: 11 residues within 4Å: Chain A: R.78, L.81, S.111, A.112, F.113, W.116, L.125, P.151, P.152, H.153 Ligands: NAP.1 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:A.112, A:W.116, A:L.125 Salt bridges: A:H.153 pi-Stacking: A:F.113 JBO.5: 12 residues within 4Å: Chain A: R.134 Chain B: R.78, S.111, A.112, F.113, W.116, L.125, H.132, P.151, P.152, H.153 Ligands: NAP.4 11 PLIP interactions: 7 interactions with chain B, 4 interactions with chain A Hydrophobic interactions: B:A.112, B:F.113, B:W.116, B:L.125 Hydrogen bonds: B:H.153 Salt bridges: B:H.153, A:R.134 pi-Stacking: B:F.113 Water bridges: A:D.130, A:D.130, A:R.134

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.3: 1 residues within 4Å: Chain A: H.183 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:H.183 SO4.6: 7 residues within 4Å: Chain A: K.137, R.140 Chain B: H.153, G.155, D.156, Q.157, V.175 6 PLIP interactions: 4 interactions with chain B, 2 interactions with chain A Hydrogen bonds: B:D.156, B:Q.157, B:Q.157 Salt bridges: B:H.153, A:R.140 Water bridges: A:R.140

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kim, M. et al., Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem. (2022)

Release Date

2022-01-19

Peptides

Flavin reductase (NADPH): AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Flavin reductase (NADPH)

Related Entries With Identical Sequence